Proto Labs, Inc. (PRLB) Key Metrics
PRLB valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $2.05B
- Enterprise value
- $1.99B
- P/E (TTM)
- 68.0 10-yr median 53.4
- Forward P/E
- 32.3
- PEG ratio
- 0.86
- Price / sales
- 3.7 10-yr median 3.7
- Price / book
- 3.1 10-yr median 2.7
- EV / EBITDA
- 27.0 10-yr median 23.2
- Dividend yield
- —
- Beta
- 1.38
PRLB key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsPRLB valuation Price multiples at each fiscal year-end price.
PRLB returns How much profit the business earns on the capital it uses.
PRLB per-share figures Results divided by the shares outstanding at year-end.
PRLB financial health Debt, liquidity and how easily interest is covered.
PRLB efficiency & capital use Working capital cycle and where the cash goes.
PRLB valuation history
PRLB returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
PRLB debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
PRLB cash returned to shareholders
PRLB price vs earnings per share
PRLB key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $1.23B | $985.5M | $1.02B | $699.8M | $1.42B | $4.13B | $2.75B | $3.08B | $2.77B | $1.36B |
| Enterprise value | $1.10B | $886.0M | $924.3M | $641.0M | $1.35B | $3.98B | $2.60B | $2.94B | $2.68B | $1.26B |
| P/E ratio | 57.7 | 59.4 | 59.3 | — | 42.6 | 81.1 | 43.2 | 40.2 | 53.4 | 31.9 |
| Price / sales | 2.3 | 2.0 | 2.0 | 1.4 | 2.9 | 9.5 | 6.0 | 6.9 | 8.0 | 4.6 |
| Price / book | 1.8 | 1.5 | 1.5 | 1.0 | 1.7 | 6.4 | 4.7 | 5.7 | 6.0 | 3.6 |
| Price / free cash flow | 20.6 | 14.4 | 22.6 | 17.3 | 67.5 | 68.8 | 51.0 | 85.9 | 56.3 | 33.0 |
| Price / operating cash flow | 16.5 | 12.7 | 13.9 | 11.3 | 25.7 | 38.6 | 23.7 | 25.0 | 33.8 | 18.2 |
| EV / sales | 2.1 | 1.8 | 1.8 | 1.3 | 2.8 | 9.2 | 5.7 | 6.6 | 7.8 | 4.2 |
| EV / EBITDA | 17.0 | 14.6 | 32.8 | — | 16.7 | 41.6 | 23.2 | 24.9 | 28.8 | 15.4 |
| EV / free cash flow | 18.5 | 12.9 | 20.5 | 15.9 | 64.2 | 66.3 | 48.3 | 82.2 | 54.5 | 30.4 |
| Earnings yield | 1.7% | 1.7% | 1.7% | −14.8% | 2.4% | 1.2% | 2.3% | 2.5% | 1.9% | 3.1% |
| Free cash flow yield | 4.9% | 7.0% | 4.4% | 5.8% | 1.5% | 1.5% | 2.0% | 1.2% | 1.8% | 3.0% |
| Dividend yield | — | — | 0.4% | 0.2% | 0.4% | 0.2% | — | — | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 3.5% | 6.1% | 4.7% | 4.7% | 2.1% | 0.5% | 1.2% | 0.4% | 0.2% | 0.0% |
| Share price at fiscal year-end | $50.59 | $39.09 | $38.96 | $25.53 | $51.35 | $153.40 | $101.55 | $112.79 | $103.00 | $51.35 |
| Per share | ||||||||||
| Revenue per share | $21.99 | $19.87 | $19.21 | $17.82 | $17.65 | $16.15 | $16.96 | $16.33 | $12.83 | $11.22 |
| Earnings per share | $0.88 | $0.66 | $0.66 | −$3.77 | $1.21 | $1.89 | $2.35 | $2.81 | $1.93 | $1.61 |
| Operating cash flow per share | $3.07 | $3.09 | $2.79 | $2.26 | $2.00 | $3.98 | $4.29 | $4.51 | $3.05 | $2.82 |
| Free cash flow per share | $2.46 | $2.72 | $1.72 | $1.47 | $0.76 | $2.23 | $1.99 | $1.31 | $1.83 | $1.56 |
| Cash per share | $5.28 | $4.09 | $3.92 | $2.92 | $2.80 | $6.01 | $5.94 | $4.83 | $3.51 | $4.08 |
| Book value per share | $27.80 | $26.58 | $26.51 | $25.45 | $29.96 | $23.96 | $21.66 | $19.85 | $17.18 | $14.30 |
| Tangible book value per share | $15.73 | $14.86 | $15.09 | $14.32 | $14.10 | $18.64 | $16.25 | $14.40 | $11.69 | $13.11 |
| Dividends per share | — | — | $0.15 | $0.06 | $0.21 | $0.28 | — | — | $0.00 | $0.00 |
| Capex per share | $0.61 | $0.36 | $1.07 | $0.79 | $1.24 | $1.75 | $2.30 | $3.19 | $1.22 | $1.27 |
| Debt per share | $0.13 | $0.14 | $0.21 | $0.78 | $0.27 | $0.50 | $0.44 | — | $0.19 | $0.00 |
| Shares outstanding | 24.2M | 25.2M | 26.2M | 27.4M | 27.7M | 26.9M | 27.0M | 27.3M | 26.8M | 26.6M |
| Change in shares outstanding | −3.8% | −3.9% | −4.3% | −0.9% | +2.8% | −0.6% | −0.8% | +1.6% | +1.1% | +0.9% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 3.2% | 2.4% | 2.5% | −13.6% | 4.5% | 8.3% | 11.3% | 15.3% | 12.3% | 12.1% |
| Return on invested capital (ROIC) | 3.2% | 2.9% | 2.8% | 3.0% | 3.7% | 10.4% | 14.8% | 19.0% | 15.6% | 15.8% |
| Return on assets (ROA) | 2.8% | 2.2% | 2.2% | −12.0% | 4.0% | 7.2% | 9.8% | 13.5% | 11.1% | 11.0% |
| Return on tangible assets | 4.3% | 3.7% | 3.6% | −20.8% | 6.8% | 8.5% | 12.1% | 16.3% | 14.0% | 11.2% |
| Free cash flow margin | 11.2% | 13.7% | 9.0% | 8.3% | 4.3% | 13.8% | 11.7% | 8.0% | 14.3% | 13.9% |
| Income quality (OCF / net income) | 3.51 | 4.69 | 4.26 | — | 1.66 | 2.10 | 1.82 | 1.61 | 1.58 | 1.76 |
| Financial health | ||||||||||
| Total debt | $3.0M | $3.5M | $5.5M | $21.4M | $7.4M | $13.3M | $11.9M | — | $5.0M | $0 |
| Cash & short-term investments | $128.1M | $103.1M | $102.8M | $80.1M | $77.5M | $161.7M | $160.7M | $131.8M | $94.1M | $108.3M |
| Net debt | −$125.1M | −$99.6M | −$97.3M | −$58.8M | −$70.1M | −$148.4M | −$148.8M | −$131.8M | −$89.1M | −$108.3M |
| Debt / equity | 0.00 | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 | — | 0.01 | 0.00 |
| Debt / assets | 0.00 | 0.00 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 | — | 0.01 | 0.00 |
| Net debt / EBITDA | −1.93 | −1.64 | −3.46 | — | −0.87 | −1.55 | −1.33 | −1.11 | −0.96 | −1.33 |
| Current ratio | 3.49 | 3.66 | 4.04 | 2.61 | 3.34 | 4.82 | 4.97 | 4.08 | 3.89 | 6.74 |
| Quick ratio | 3.27 | 3.43 | 3.76 | 2.42 | 3.10 | 4.60 | 4.76 | 3.89 | 3.63 | 6.34 |
| Interest coverage | — | 127.5 | 25.6 | 0.2 | 176.2 | 19.2 | 59.7 | — | — | — |
| Working capital | $166.5M | $141.6M | $151.0M | $115.0M | $128.6M | $191.7M | $188.8M | $162.6M | $122.6M | $134.4M |
| Invested capital | $548.9M | $570.6M | $598.0M | $638.9M | $758.4M | $496.0M | $437.0M | $409.7M | $372.1M | $271.6M |
| Tangible asset value | $381.3M | $374.7M | $395.7M | $392.4M | $389.9M | $501.3M | $439.7M | $392.9M | $313.8M | $348.3M |
| Net current asset value | $123.8M | $121.5M | $123.6M | $82.0M | $83.4M | $142.2M | $148.5M | $137.9M | $108.9M | $123.4M |
| Graham number | $23.41 | $19.84 | $19.79 | — | $28.52 | $31.93 | $33.86 | $35.41 | $27.31 | $22.74 |
| Graham net-net per share | $3.57 | $3.49 | $3.39 | $1.55 | $1.63 | $4.13 | $4.47 | $3.96 | $3.11 | $3.93 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | $3.8M | $1.7M | $5.9M | $7.6M | — | — | $0 | $0 |
| Share buybacks (net) | $43.0M | $60.3M | $44.0M | $31.3M | $23.3M | $14.7M | $33.5M | $12.2M | $4.4M | $0 |
| Dividend payout ratio | — | — | 22.3% | — | 17.6% | 14.9% | — | — | 0.0% | 0.0% |
| Dividends + buybacks / free cash flow | 72.0% | 87.8% | 105.8% | 81.8% | 138.5% | 37.1% | 62.3% | 34.1% | 9.0% | 0.0% |
| Capex / revenue | 2.8% | 1.8% | 5.6% | 4.4% | 7.0% | 10.8% | 13.6% | 19.5% | 9.5% | 11.3% |
| Capex / operating cash flow | 19.9% | 11.8% | 38.4% | 34.9% | 61.9% | 43.9% | 53.6% | 70.9% | 39.9% | 44.8% |
| Capex / depreciation | 0.44 | 0.26 | 0.75 | 0.55 | 0.84 | 1.44 | 2.02 | 3.26 | 1.77 | 1.92 |
| Stock-based compensation / revenue | 3.0% | 3.4% | 3.2% | 3.6% | 3.9% | 3.4% | 2.4% | 2.5% | 2.5% | 2.3% |
| R&D / revenue | 8.0% | 8.2% | 8.0% | 7.8% | 9.1% | 8.5% | 7.1% | 6.4% | 6.8% | 7.5% |
| SG&A / revenue | 31.5% | 31.2% | 30.5% | 30.8% | 28.3% | 27.9% | 26.8% | 27.2% | 28.5% | 27.8% |
| Efficiency | ||||||||||
| Days sales outstanding | 51.6 | 52.6 | 56.3 | 60.4 | 52.3 | 48.7 | 48.7 | 48.4 | 46.5 | 46.9 |
| Days of inventory on hand | 16.5 | 17.1 | 17.6 | 17.9 | 16.5 | 17.6 | 16.5 | 18.8 | 24.9 | 26.6 |
| Days payables outstanding | 18.9 | 20.5 | 21.4 | 28.6 | 30.0 | 29.5 | 27.9 | 29.4 | 32.9 | 34.7 |
| Cash conversion cycle (days) | 49.2 | 49.2 | 52.5 | 49.7 | 38.8 | 36.8 | 37.2 | 37.9 | 38.5 | 38.7 |
| Receivables turnover | 7.07 | 6.93 | 6.49 | 6.04 | 6.98 | 7.50 | 7.50 | 7.54 | 7.84 | 7.78 |
| Payables turnover | 19.34 | 17.83 | 17.09 | 12.78 | 12.17 | 12.36 | 13.06 | 12.43 | 11.08 | 10.50 |
| Inventory turnover | 22.17 | 21.39 | 20.70 | 20.41 | 22.10 | 20.69 | 22.16 | 19.38 | 14.64 | 13.74 |
| Asset turnover | 0.70 | 0.66 | 0.64 | 0.56 | 0.58 | 0.61 | 0.71 | 0.78 | 0.74 | 0.77 |
| Average receivables | $75.4M | $72.2M | $77.7M | $80.8M | $69.9M | $57.9M | $61.2M | $59.1M | $43.9M | $38.3M |
| Average payables | $15.3M | $15.6M | $16.5M | $21.4M | $21.8M | $17.5M | $17.1M | $16.6M | $13.6M | $12.5M |
| Average inventory | $13.4M | $13.0M | $13.6M | $13.4M | $12.0M | $10.5M | $10.1M | $10.7M | $10.3M | $9.5M |
| Intangibles / total assets | 37.3% | 39.7% | 38.8% | 38.1% | 47.2% | 19.2% | 21.7% | 24.0% | 28.5% | 7.6% |
Computed from PRLB's annual financial statements (latest annual report filed February 20, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
PRLB valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Proto Labs traded at 57.7 times earnings, against a 10-year median of 53.4. Based on the latest twelve months, the trailing P/E is 68.0 and the forward P/E is 32.3. Proto Labs earned a return on equity of 3.2% and a return on invested capital of 3.2% in fiscal 2025. It ended the year with $3.0 million of debt and $128.1 million in cash and short-term investments, a net cash position of $125.1 million. It returned $43.0 million to shareholders: $0 in dividends and $43.0 million in share buybacks, 72% of free cash flow. The share count fell 8.7% from 26.6M to 24.2M over 9 years.
See the PRLB income statement, the PRLB chart for price history, or the PRLB stock overview for the latest quote and news.
PRLB key metrics FAQ
What is Proto Labs's P/E ratio?
Proto Labs's trailing P/E ratio is 68.0 based on the last twelve months of earnings (as of October 17, 2026), and its forward P/E is 32.3. At the end of fiscal 2025 it was 57.7, compared with a 10-year median of 53.4.
What is Proto Labs's EV/EBITDA?
Proto Labs's enterprise value was 17.0 times EBITDA at the end of fiscal 2025 (enterprise value $1.1 billion, EBITDA $64.9 million); the current EV/EBITDA is 27.0.
What is Proto Labs's return on equity?
Proto Labs's return on equity (ROE) was 3.2% in fiscal 2025: net income of $21.2 million on average shareholders' equity of $672.0 million.
What is Proto Labs's ROIC?
Proto Labs's return on invested capital was 3.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Proto Labs have?
Proto Labs had total debt of $3.0 million at the end of fiscal 2025, a debt-to-equity ratio of 0.00 and more cash than debt.
Does Proto Labs buy back its shares?
Yes. Proto Labs spent $43.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −3.8% over the year, to 24.2M..
What is Proto Labs's free cash flow yield?
Proto Labs generated $59.7 million of free cash flow in fiscal 2025, a free cash flow yield of 4.9% on its market value at year-end ($1.2 billion).
What is Proto Labs's current ratio?
Proto Labs's current ratio was 3.49 at the end of fiscal 2025: current assets were 3.49 times current liabilities.